You are here: Home:Audio Program Guide: BCU Surgeons 3 | 2006 Audio: BCU Surgeons 3 | 2006     Go to interview with Rache M Simmons, MD Go to interview with Peter M Ravdin, MD, PhD Go to interview with Henry M Kuerer, MD, PhD Go to interview with Debu Tripathy, MD Go to interview with D Lawrence Wickerham, MD Go to interview with Richard Sainsbury, MD   To listen to individual tracks, click the on the track you wish to listen to. To download tracks, right-click on the one you wish to download.       Rache M Simmons, MD Associate Professor of Surgery The New York Presbyterian Hospital-Weill Medical College Cornell University New York, New York     Click here to download the entire interview   Track 1 Introduction Track 2 Developing technologies as alternatives to surgical lumpectomy Track 3 Phase II multi-institutional trial of cryoablation followed by surgical resection Track 4 Cosmetic results with cryoablation compared to standard excision Track 5 Partial breast irradiation Track 6 Sentinel lymph node biopsy Track 7 Skin-sparing and areola-sparing mastectomy Track 8 Adjuvant aromatase inhibitors for postmenopausal patients with hormone receptor-positive disease Track 9 Utility of the Oncotype DX™ assay       Peter M Ravdin, MD, PhD Clinical Professor of Medicine The University of Texas Health Science Center at San Antonio San Antonio, Texas     Click here to download the entire interview   Track 1 Introduction Track 2 Development of the Oncotype DX assay Track 3 Utility of the Oncotype DX assay in predicting benefit from chemotherapy Track 4 Selection of hormonal therapy for postmenopausal patients with hormone receptor-positive disease Track 5 Use of aromatase inhibitors in premenopausal women with chemotherapy-induced amenorrhea Track 6 Ovarian suppression or ablation with aromatase inhibitors for premenopausal patients Track 7 Comparison of side effects between aromatase inhibitors and tamoxifen       Henry M Kuerer, MD, PhD Director, Breast Surgical Oncology Training Program Department of Surgical Oncology The University of Texas MD Anderson Cancer Center Houston, Texas     Click here to download the entire interview   Track 1 Introduction Track 2 Clinical trials evaluating trastuzumab in patients with DCIS Track 3 Side effects of tamoxifen and aromatase inhibitors Track 4 Inaccuracies in the assessment of ER and HER2 status Track 5 Radiation therapy after surgery in patients with DCIS Track 6 Partial breast irradiation Track 7 Sentinel lymph node biopsy in the neoadjuvant setting Track 8 Clinical trials of neoadjuvant hormonal therapy       Debu Tripathy, MD Professor of Internal Medicine Director, Komen UT Southwestern Breast Cancer Research Program University of Texas Southwestern Medical Center Dallas, Texas     Click here to download the entire interview   Track 1 Introduction Track 2 Case discussion: A 42-year-old woman with node-negative, ER-positive, PR-positive, HER2-negative disease Track 3 Incorporation of the Oncotype DX assay into clinical practice Track 4 Adjuvant hormonal therapy for premenopausal and postmenopausal women with hormone receptor-positive disease Track 5 Comparison of side effects between aromatase inhibitors and tamoxifen Track 6 Duration of adjuvant aromatase inhibitor therapy Track 7 Ovarian suppression or ablation with aromatase inhibitors for premenopausal patients Track 8 Selection of hormonal therapy for premenopausal patients with chemotherapy-induced amenorrhea Track 9 Hormonal therapy for patients with hormone receptor-positive, HER2-positive disease Track 10 Adjuvant trastuzumab in patients with HER2-positive disease Track 11 Future strategies in systemic therapy of breast cancer Track 12 Biologic classification of breast cancer       D Lawrence Wickerham, MD Associate Chairman National Surgical Adjuvant Breast and Bowel Project (NSABP) Associate Professor of Human Oncology Drexel University School of Medicine Pittsburgh, Pennsylvania     Click here to download the entire interview   Track 1 Introduction Track 2 NSABP-P-2: STAR prevention trial comparing tamoxifen to raloxifene Track 3 Clinical implications of the STAR trial results Track 4 NSABP-P-4: STELLAR prevention trial comparing raloxifene to letrozole Track 5 Investigations of quality of life and compliance with long-term oral breast cancer treatment       Richard Sainsbury, MD Senior Lecturer, Department of Surgery University College London London, United Kingdom     Click here to download the entire interview   Track 1 Introduction Track 2 Use of adjuvant aromatase inhibitors in postmenopausal patients with hormone receptor-positive disease Track 3 Comparison of the side effects of aromatase inhibitors and tamoxifen Track 4 Management of decreased bone density associated with aromatase inhibitors Track 5 Aromatase inhibitor-associated arthralgias Track 6 Cardiac event rates with letrozole, exemestane and anastrozole Track 7 Neoadjuvant hormonal therapy Track 8 IBIS-2 trials for patients at high risk or with ductal carcinoma in situ   Search Our Site

Terms and Conditions of Use and General Disclaimer Copyright © 2006 Research To Practice, All Rights Reserved